scholarly journals Partial aneurysmectomy for treatment of autologous hemodialysis fistula aneurysm is safe and effective

2019 ◽  
Vol 70 (2) ◽  
pp. 547-553 ◽  
Author(s):  
Ziming Wan ◽  
Qiquan Lai ◽  
Yu Zhou ◽  
Liqun Chen ◽  
Bo Tu
Keyword(s):  
2020 ◽  
Vol 62 (10) ◽  
pp. 1341-1344
Author(s):  
Jun Haruma ◽  
Simon Escalard ◽  
Stanislas Smajda ◽  
Michel Piotin

2017 ◽  
Vol 2 (3) ◽  
pp. 332-341 ◽  
Author(s):  
Jonathan P. Rehfuss ◽  
Scott A. Berceli ◽  
Sarah M. Barbey ◽  
Yong He ◽  
Paul S. Kubilis ◽  
...  
Keyword(s):  

2017 ◽  
Vol 18 (1_suppl) ◽  
pp. S114-S117 ◽  
Author(s):  
Bram M. Voorzaat ◽  
Jan van Schaik ◽  
Koen E.A. van der Bogt ◽  
Liffert Vogt ◽  
Laurens Huisman ◽  
...  

Background Non-maturation is a frequent complication of radiocephalic arteriovenous fistulas (RCAVF). In an animal model, liposomal prednisolone improved maturation of experimental fistulas. The Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation (LIPMAT) study investigates if liposomal prednisolone improves RCAVF maturation. Methods and results The LIPMAT study is an investigator-initiated, multicenter, double-blinded, placebo-controlled randomized controlled trial with 1:1 randomization to liposomal prednisolone or placebo. Eighty patients receiving an RCAVF will be included. The primary outcome is the cephalic vein diameter six weeks after surgery, measured by ultrasound. The LIPMAT study started in May 2016. Enrollment is expected to be completed by the end of 2017. Conclusions The LIPMAT study is the first to evaluate the efficacy of liposomal prednisolone to enhance RCAVF maturation.


2007 ◽  
Vol 56 (5) ◽  
pp. 451
Author(s):  
Tae-Beom Shin ◽  
Jin-Jong You ◽  
Jae-Min Cho ◽  
Dae-Seob Choi ◽  
Jae-Wook Ryoo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document